WHO clinical trial change management – Clinical Research Made Simple https://www.clinicalstudies.in Trusted Resource for Clinical Trials, Protocols & Progress Fri, 26 Sep 2025 11:01:52 +0000 en-US hourly 1 https://wordpress.org/?v=6.9.1 SOP for Change Control Management https://www.clinicalstudies.in/sop-for-change-control-management/ Fri, 26 Sep 2025 11:01:52 +0000 ]]> https://www.clinicalstudies.in/?p=7040 Read More “SOP for Change Control Management” »

]]>
SOP for Change Control Management

{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.clinicalstudies.in/sop-for-change-control-management”
},
“headline”: “SOP for Change Control Management”,
“description”: “This SOP establishes procedures for Change Control Management in clinical research, ensuring compliance with FDA, EMA, CDSCO, WHO, and ICH GCP guidelines. It defines processes for initiating, assessing, approving, implementing, and documenting changes in systems, processes, protocols, and vendors.”,
“author”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”
},
“publisher”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”,
“logo”: {
“@type”: “ImageObject”,
“url”: “https://www.clinicalstudies.in/logo.png”
}
},
“datePublished”: “2025-08-26”,
“dateModified”: “2025-08-26”
}

Standard Operating Procedure for Change Control Management

SOP No. CR/OPS/100/2025
Supersedes NA
Page No. 1 of 45
Issue Date 26/08/2025
Effective Date 01/09/2025
Review Date 01/09/2026

Purpose

The purpose of this SOP is to define the process for effective Change Control Management in clinical research. Changes in systems, processes, vendors, and trial protocols must be controlled, documented, and approved to ensure compliance with ICH GCP, FDA, EMA, CDSCO, and WHO requirements. This SOP ensures changes are managed in a structured, risk-based, and traceable manner.

Scope

This SOP applies to sponsors, CROs, investigators, QA, vendors, and clinical site staff involved in clinical trial activities. It covers changes related to trial protocols, SOPs, computerized systems, investigational product handling, data management systems, QMS, and vendor management processes.

Responsibilities

  • Sponsor: Defines and oversees change control policies across clinical programs.
  • QA: Reviews and approves change control records and ensures regulatory compliance.
  • Investigators: Implement and document site-level changes in ISF/TMF.
  • CROs: Escalate changes to sponsors and maintain documentation.
  • Vendors: Seek approval before implementing changes that impact trial processes.

Accountability

The Sponsor’s Quality Head is accountable for ensuring changes are controlled, risk-assessed, documented, and implemented effectively. QA is accountable for auditing and verifying compliance of the change control process.

Procedure

1. Initiation
1.1 Any proposed change must be documented in the Change Control Request Form (Annexure-1).
1.2 Submit the request to QA for review.

2. Impact and Risk Assessment
2.1 Assess risks associated with the change, including impact on subject safety, data integrity, and regulatory compliance.
2.2 Record the assessment in Change Control Risk Log (Annexure-2).

3. Review and Approval
3.1 QA reviews all proposed changes for compliance with GCP and regulatory guidelines.
3.2 Obtain approval from the Sponsor and relevant stakeholders.
3.3 Document decisions in Change Control Approval Log (Annexure-3).

4. Implementation
4.1 Implement approved changes according to defined timelines.
4.2 Train staff on changes and document training in Training Log.
4.3 Update relevant SOPs, TMF, and ISF records.

5. Verification
5.1 QA verifies that changes were implemented as planned.
5.2 Maintain Change Implementation Verification Log (Annexure-4).

6. Documentation and Archiving
6.1 Archive all change control records in TMF.
6.2 Retain records as per global retention timelines.

Abbreviations

  • SOP: Standard Operating Procedure
  • QA: Quality Assurance
  • CRO: Contract Research Organization
  • TMF: Trial Master File
  • ISF: Investigator Site File
  • QMS: Quality Management System

Documents

  1. Change Control Request Form (Annexure-1)
  2. Change Control Risk Log (Annexure-2)
  3. Change Control Approval Log (Annexure-3)
  4. Change Implementation Verification Log (Annexure-4)

References

Version: 1.0

Approval Section

Prepared By Ravi Kumar, QA Specialist
Checked By Sunita Reddy, QA Officer
Approved By Dr. Anil Sharma, Head Clinical Quality

Annexures

Annexure-1: Change Control Request Form

Date Requested By Description of Change Reason
01/09/2025 Meena Sharma Update EDC System Vendor upgrade

Annexure-2: Change Control Risk Log

Date Change ID Risk Identified Impact Mitigation
05/09/2025 CC-2025-01 Data migration risk High Perform validation

Annexure-3: Change Control Approval Log

Date Change ID Approved By Decision Remarks
10/09/2025 CC-2025-01 Sponsor QA Approved Proceed with validation

Annexure-4: Change Implementation Verification Log

Date Change ID Verified By Result Status
20/09/2025 CC-2025-01 QA Manager Implementation successful Closed

Revision History

Revision Date Revision No. Revision Details Reason for Revision Approved By
26/08/2025 00 Initial version New SOP creation Head Clinical Quality

For more SOPs visit: Pharma SOP

]]>